TGF-beta activation modulators (Pliant Therapeutics)

N/A

Report date: 2025/03/19 18:26:13
NME

Base Information

Drug NameTGF-beta activation modulators (Pliant Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta 1 modulators
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPliant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPliant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A